FI67876C - Foerfarande foer framstaellning av antimikrobiellt och antitumoert verkande derivat av tallysomycin a och tallysomycin b - Google Patents

Foerfarande foer framstaellning av antimikrobiellt och antitumoert verkande derivat av tallysomycin a och tallysomycin b Download PDF

Info

Publication number
FI67876C
FI67876C FI802198A FI802198A FI67876C FI 67876 C FI67876 C FI 67876C FI 802198 A FI802198 A FI 802198A FI 802198 A FI802198 A FI 802198A FI 67876 C FI67876 C FI 67876C
Authority
FI
Finland
Prior art keywords
tallysomycin
och
derivatives
fermentation
tallycomycin
Prior art date
Application number
FI802198A
Other languages
English (en)
Finnish (fi)
Other versions
FI802198A (fi
FI67876B (fi
Inventor
Takeo Miuaki
Osamu Tenmyo
Masataka Konishi
Hiroshi Kawaguchi
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of FI802198A publication Critical patent/FI802198A/fi
Application granted granted Critical
Publication of FI67876B publication Critical patent/FI67876B/fi
Publication of FI67876C publication Critical patent/FI67876C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K9/00Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/003Peptides being substituted by heterocyclic radicals, e.g. bleomycin, phleomycin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Claims (3)

1. Förfarande för framställning av ett antimikro-biellt och antitumört verkande der ivat av tallysomycin A med formeIn (Ia) CO-nh2 nh2 0 ^
1 N_pC-NH-(CH2)3-CH-CH2-C-R N^N ° o "H2 K '1 „ un _
2 Jk AH-CH-k rJ H^'VS50 0HY^rNY^N^ ' H,C o H0_ J TTjj a 4V 0h| H2N OH U0-^-OH V-'T'-k-OH HO A 0"^NH2 där R är -NH- (CH2) 3“^^2 -nh-(ch2)3-s®(ch3)2 -nh-(ch2)3-nh-ch2-ch2oh -nh-(ch2)3-n(ch2ch2oh)2 -nh-(ch2)4-nh2 -MH-(CH2)3-NH-CH3 eller -HH-(CH2)j-«H-CH-Q , ch3 samt derivat av tallysomycin B med formeln (Ib) 67876 36 co-nh2 nh2 q ^ 0 o ",-AJ oHY^Syk^SH-CH-kT^ HW Y H!%^ Γ^^--ο H I oh I OH I H*N 0H Uq^-OH γ-τ-^-οΗ HO X Q'^mz där R är , , -nh-(ch2)3-nh2 -nh-(ch2)3-s®(ch3)2 -NH-(CH2)2-NH2 -NH-CH2-CH-CH2-NH2 OH -NH-(CH2)2-NH-CH2-CH-CH3 OH -NH-(CH2)3-NH-CH2-CH2OH -MH-(CH2)3-N(CH3)2· -NH-(CH2)3-N(CH2CH2OH)2 -NH-(CH2)2-NH-CH2-CH2OH -NH-(CH2)d-NH2 -NH-(CH2)3-NH-CH3 -NH-(CH2)3-N^J0 eller -NH-(CH2)3-n£^ ch3 -NH-(CH2)3-NH-CH-^~^ ^3 67876 37 eller farmaceutiskt godtagbara syraadditionssalter därav genom odling av en tallysomycin-producerande stam av Streptoalloteichus hindustanus i ett vattenhaltigt nSrings-medium, kännetecknat därav, att odlingen genomförs i närvaro av en aminprekursorförening med formeln NH2-(CH2)2-NH2, nh2-(ch2)3-nh2, NH2-(CH2)4-NH2, NH2-CH2-CH-CH2-NH2, OH NH2-(CH2)2-NH-CH2-CH2OH, NH2-(CH2)2-NH-CH2-CH-CH3, OH NH2-(CH2)3-NH-CH3, nh2-(ch2)3-nh-ch2-ch2oh, nh2-(ch2)3-nh-ch^) , CH3 NH2-(CH2)3-N(CH3)2, NH2-(CH2)3-N(CH2CH20H)2, NH2-(CH2)3-Q, eller nh2-(ch2)3-n^) ch3 nh2-(ch2)3-s®(ch3)2, Cl®
FI802198A 1979-07-13 1980-07-09 Foerfarande foer framstaellning av antimikrobiellt och antitumoert verkande derivat av tallysomycin a och tallysomycin b FI67876C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/057,528 US4246400A (en) 1979-07-13 1979-07-13 Tallysomycin compounds
US5752879 1979-07-13

Publications (3)

Publication Number Publication Date
FI802198A FI802198A (fi) 1981-01-14
FI67876B FI67876B (fi) 1985-02-28
FI67876C true FI67876C (fi) 1985-06-10

Family

ID=22011128

Family Applications (1)

Application Number Title Priority Date Filing Date
FI802198A FI67876C (fi) 1979-07-13 1980-07-09 Foerfarande foer framstaellning av antimikrobiellt och antitumoert verkande derivat av tallysomycin a och tallysomycin b

Country Status (26)

Country Link
US (1) US4246400A (sv)
JP (1) JPS5659793A (sv)
AU (1) AU533469B2 (sv)
BE (1) BE884291A (sv)
CA (1) CA1144494A (sv)
CH (1) CH646982A5 (sv)
CY (1) CY1317A (sv)
DE (1) DE3026425A1 (sv)
DK (1) DK151633C (sv)
ES (1) ES8106554A1 (sv)
FI (1) FI67876C (sv)
FR (1) FR2460961A1 (sv)
GB (1) GB2053221B (sv)
GR (1) GR82324B (sv)
HK (1) HK8286A (sv)
IE (1) IE50020B1 (sv)
IL (1) IL60541A (sv)
IT (1) IT1174296B (sv)
LU (1) LU82612A1 (sv)
MY (1) MY8800097A (sv)
NL (1) NL8003970A (sv)
NO (1) NO155701C (sv)
NZ (1) NZ193921A (sv)
SE (1) SE449751B (sv)
YU (1) YU43218B (sv)
ZA (1) ZA804150B (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4650765A (en) * 1981-02-23 1987-03-17 American Cyanamid Company Biologically pure culture of Streptoverticillium stramineum sp. nov.
EP0058838A1 (en) * 1981-02-23 1982-09-01 American Cyanamid Company Antibiotic LL BO1208 alpha and LL BO1208 beta
JPH02267083A (ja) * 1989-04-07 1990-10-31 Nissan Motor Co Ltd 自動車のフロントボデー補強構造
US5420228A (en) * 1991-04-05 1995-05-30 University Of Pittsburgh Of The Commonwealth System Of Higher Education Fluorescent-labelled bleomycin analogues

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1038242A (en) * 1963-03-05 1966-08-10 Zaidan Hojin Biseibutsu Bleomycin and processes for preparation thereof
GB1292081A (en) * 1969-02-15 1972-10-11 Zaidan Hojin Biseibutsu Process for producing bleomycin antibiotics
US3846400A (en) * 1969-02-15 1974-11-05 Microbial Chem Res Found Novel process for producing antibiotics bleomycin
US3814796A (en) * 1969-10-09 1974-06-04 Upjohn Co Antibiotics zorbonomycin and zorbonomycin b and process for the preparation thereof
US3922262A (en) * 1971-04-28 1975-11-25 Nippon Kayaku Kk N-Substituted derivatives of bleomycins
JPS5739751B2 (sv) * 1972-03-03 1982-08-23
US4051237A (en) * 1975-08-28 1977-09-27 Bristol-Myers Company Glycopeptide antibiotics bu-2231 a and b and process for producing same
US4195018A (en) * 1977-07-01 1980-03-25 Nippon Kayaku Kabushiki Kaisha 3-[(S)-1'-Phenylethylamino]propylaminobleomycin, non-toxic salt thereof, and method for producing same

Also Published As

Publication number Publication date
CY1317A (en) 1986-03-28
JPS6328080B2 (sv) 1988-06-07
HK8286A (en) 1986-02-14
IL60541A (en) 1983-12-30
YU43218B (en) 1989-06-30
GR82324B (sv) 1984-12-13
IT1174296B (it) 1987-07-01
IT8049183A0 (it) 1980-07-07
DK151633C (da) 1988-06-20
SE449751B (sv) 1987-05-18
FR2460961B1 (sv) 1983-11-18
DE3026425C2 (sv) 1989-11-09
NZ193921A (en) 1982-09-14
AU533469B2 (en) 1983-11-24
GB2053221A (en) 1981-02-04
IL60541A0 (en) 1980-09-16
NO155701B (no) 1987-02-02
AU5919080A (en) 1981-01-15
LU82612A1 (fr) 1981-02-02
NL8003970A (nl) 1981-01-15
DK297980A (da) 1981-01-14
NO802048L (no) 1981-01-14
DE3026425A1 (de) 1981-01-29
ZA804150B (en) 1981-07-29
FI802198A (fi) 1981-01-14
US4246400A (en) 1981-01-20
BE884291A (fr) 1981-01-12
YU143580A (en) 1983-04-30
SE8005134L (sv) 1981-01-14
ES493350A0 (es) 1981-07-01
GB2053221B (en) 1983-05-05
IE50020B1 (en) 1986-02-05
DK151633B (da) 1987-12-21
CA1144494A (en) 1983-04-12
FI67876B (fi) 1985-02-28
JPS5659793A (en) 1981-05-23
NO155701C (no) 1987-05-13
IE801444L (en) 1981-01-13
CH646982A5 (fr) 1984-12-28
MY8800097A (en) 1988-12-31
ES8106554A1 (es) 1981-07-01
FR2460961A1 (fr) 1981-01-30

Similar Documents

Publication Publication Date Title
JPH0637508B2 (ja) 抗生物質A40926複合体およびその純粋な因子PA、PB、A、BおよびBo
CA1175763A (en) Antibiotic bmg162-af2, a process for production thereof, and antitumor drug containing said new antibiotic as active ingredient
EP0287110B1 (en) Glycopeptide antibiotics pa-45052
FI67876B (fi) Foerfarande foer framstaellning av antimikrobiellt och antitumoert verkande derivat av tallysomycin a och tallysomycin b
US4326054A (en) Cleomycins and process for producing same
FI71765C (sv) Förfarande för framställning av arfamenin.
US4550159A (en) Anthracycline compounds
Miyaki et al. TALLYSOMYCIN, A NEW ANTITUMOR ANTIBIOTIC COMPLEX RELATED TO BLEOMYCIN V. PRODUCTION, CHARACTERIZATION AND ANTITUMOR ACTIVITY OF TALLYSOMYCIN S 10b, A NEW BIOSYNTHETIC TALLYSOMYCIN DERIVATIVE
US4548924A (en) Antibiotics M43B and M43C, pharmaceutical composition and method of use
US4956293A (en) Nocardia sp. ATCC 53492, or an antibiotic A 42867 producing mutant or variant thereof
Katayama et al. SPERABILLINS, NEW ANTIBACTERIAL ANTIBIOTICS WITH POTENT IN VIVO ACTIVITY TAXONOMY, FERMENTATION, ISOLATION AND BIOLOGICAL ACTIVITY
GB2048855A (en) Istamycins
US4314028A (en) Fermentation process for producing tallysomycin compounds
US5451581A (en) Antibiotic LL-14E605β and O-methyl-LL-14E605β
KR100199650B1 (ko) 신규 만노실 테이코플라닌 아글리콘 및 만노실 테이코플라닌유도체의 제조방법
US4565861A (en) Serirubicum
US4816559A (en) Biologically active peptides TAN-866
PL80573B1 (sv)
HORI et al. A NEW ANTITUMOR ANTIBIOTIC, CHROMOXYMYCIN II. PRODUCTION, ISOLATION, CHARACTERIZATION AND ANTITUMOR ACTIVITY
US4792545A (en) Boholmycin antibiotic
Sawada et al. A new streptothricin antibiotic, R4H
JPS61233655A (ja) バラニマイシン及びその誘導体、並びにそれらの製造法

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: BRISTOL-MYERS CO